Results
1 -
10 of
16
(Click
here to explore results)
- Design of a platinum–acridine–endoxifen conjugate targeted at hormone-dependent breast cancer. Song Ding, Xin Qiao, Gregory L. Kucera, Ulrich Bierbach
, Chem. Commun.
, 2013
, 49
, 2415
- Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents. S. Ding, U. Bierbach
, Dalton Trans.
, 2016
, 45
, 13104
- Small hybrid heteroaromatics: resourceful biological tools in cancer research. Vikrant Abbot, Poonam Sharma, Saurabh Dhiman, Malleshappa N. Noolvi, Harun M. Patel, Varun Bhardwaj
, RSC Adv.
, 2017
, 7
, 28313
- Mechanisms of allosteric and mixed mode aromatase inhibitors. Samson A. Souza, Abby Held, Wenjie J. Lu, Brendan Drouhard, Bryant Avila, Raul Leyva-Montes, Michelle Hu, Bill R. Miller, Ho Leung Ng
, RSC Chem. Biol.
, 2021
, 2
, 892
- Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization. Kenward Vong, Tomoya Yamamoto, Tsung-che Chang, Katsunori Tanaka
, Chem. Sci.
, 2020
, 11
, 10928
- Prodrug strategies for targeted therapy triggered by reactive oxygen species. Jorge Peiró Cadahía, Viola Previtali, Nikolaj S. Troelsen, Mads H. Clausen
, Med. Chem. Commun.
, 2019
, 10
, 1531
- 1,2,4-Oxadiazole-5-ones as analogues of tamoxifen: synthesis and biological evaluation. Maria A. Chiacchio, Laura Legnani, Agata Campisi, Bottino Paola, Lanza Giuseppe, Daniela Iannazzo, Lucia Veltri, Salvatore Giofrè, Roberto Romeo
, Org. Biomol. Chem.
, 2019
, 17
, 4892
- Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy. Vellingiri Yasothamani, Raju Vivek
, J. Mater. Chem. B
, 2022
, 10
, 6392
- Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer. Shagufta, Irshad Ahmad, Shimy Mathew, Sofia Rahman
, RSC Med. Chem.
, 2020
, 11
, 438
- Design, synthesis, and biological evaluation of indole-modified tamoxifen relatives as potent anticancer agents. Berrak Ertugrul, Abdulmelik Aytatli, Omer Faruk Karatas, Nurullah Saracoglu
, RSC Med. Chem.
, 2023
, 14
, 1362